{"schema_version":"secwatch.filing_event.v1","accession":"0001279569-24-000553","form_type":"8-K","ticker":"CWBHF","cik":"0001750155","company_name":"Charlotte's Web Holdings, Inc.","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.884359+00:00","generated_at":"2026-06-02T11:56:28.509648+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Charlotte's Web Q1 revenue falls 29% to $12.1M; net loss widens to $9.7M","bullets":["Revenue $12.1M (down 29% YoY); net loss $9.7M vs $2.9M loss in Q1 2023.","Adjusted EBITDA loss $4.0M vs loss $3.3M; SG&A reduced 12.8% to $15.3M.","Cash and working capital $38.5M and $48.6M; net cash used in ops $7.2M.","Targets $15M SG&A reduction in 2024; e-commerce platform migration on track for Q2 launch.","DeFloria completes Phase 1 trial dosing; IND submission to FDA planned this year."],"urls":{"canonical":"https://secwatch.observer/filing/0001279569-24-000553","json":"https://secwatch.observer/filing/0001279569-24-000553.json","markdown":"https://secwatch.observer/filing/0001279569-24-000553.md","text":"https://secwatch.observer/filing/0001279569-24-000553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1750155/000127956924000553/0001279569-24-000553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1750155/000127956924000553/charlotteweb8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T11:56:28.509648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f7ca965079c98adbbd22fe8a0592ff99a83e92b6","claim":"Charlotte's Web Holdings, Inc. reported first quarter ended March 31, 2024 results: revenue $12.1, net income $(9.7), EPS $(0.06).","evidence_excerpt":"The following table sets forth selected financial information for the periods indicated. Three Months Ended, March 31, U.S. $ millions, except per share data 2024 2023 Revenue $12.1 $17.0 Cost of goods sold 5.2 7.1 Gross profit 6.9 9.9 Selling, general and administrative expenses 15.3 17.5 Operating loss (8.4) (7.6) Other income (expense), net 0.6 (0.7)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1750155/000127956924000553/0001279569-24-000553-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$12.1"},{"label":"Net income","value":"$(9.7)"},{"label":"EPS","value":"$(0.06)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}